Cortisol Metabolism in Inflammation and Sepsis

  • B. Venkatesh
  • J. Cohen
Conference paper


Steroid therapy has not been consistently shown to provide benefit in severe sepsis and may even be associated with adverse effects. The driver for steroid therapy is based on the controversial and unproven premise that there is relative adrenal insufficiency (based on a blunted cortisol response to corticotropin) in septic shock [1].


Septic Shock Chronic Fatigue Syndrome Glycyrrhetinic Acid Relative Adrenal Insufficiency Total Cortisol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Venkatesh B, Prins J, Torpy D, et al (2006) Relative adrenal insufficiency in sepsis: match point or deuce? Crit Care Resusc 8:376–380PubMedGoogle Scholar
  2. 2.
    Seckl JR, Walker BR (2001) Minireview: 11beta-hydroxysteroid dehydrogenase type 1-a tissue-specific amplifier of glucocorticoid action. Endocrinology 142:1371–1376PubMedCrossRefGoogle Scholar
  3. 3.
    Stewart PM, Krozowski ZS (1999) 11 beta-Hydroxysteroid dehydrogenase. Vitam Horm 57: 249–324PubMedCrossRefGoogle Scholar
  4. 4.
    Beishuizen A, Thijs LG, Vermes I (2001) Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 27:1584–1591PubMedCrossRefGoogle Scholar
  5. 5.
    Hamrahian AH, Oseni TS, Arafah BM (2004) Measurements of serum free cortisol in critically ill patients. N Engl J Med 350:1629–1638PubMedCrossRefGoogle Scholar
  6. 6.
    Morris DJ, Latif SA, Hardy MP, Brem AS (2007) Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol. J Steroid Biochem Mol Biol 104:161–168PubMedCrossRefGoogle Scholar
  7. 7.
    Vicker N, Su X, Ganeshapillai D, et al (2007) Novel non-steroidal inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. J Steroid Biochem Mol Biol 104:123–129PubMedCrossRefGoogle Scholar
  8. 8.
    Nomura S, Fujitaka M, Sakura N, Ueda K (1997) Circadian rhythms in plasma cortisone and cortisol and the cortisone/cortisol ratio. Clin Chim Acta 266:83–91PubMedCrossRefGoogle Scholar
  9. 9.
    Jerjes WK, Cleare AJ, Wessely S, Wood PJ, Taylor NF (2005) Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome. J Affect Disord 87:299–304PubMedCrossRefGoogle Scholar
  10. 10.
    Escher G, Galli I, Vishwanath BS, Frey BM, Frey FJ (1997) Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle. J Exp Med 186:189–198PubMedCrossRefGoogle Scholar
  11. 11.
    Cooper MS, Bujalska I, Rabbitt E, et al (2001) Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. J Bone Miner Res 16:1037–1044PubMedCrossRefGoogle Scholar
  12. 12.
    Cai TQ, Wong B, Mundt SS, Thieringer R, Wright SD, Hermanowski-Vosatka A (2001) Induction of 11beta-hydroxysteroid dehydrogenase type 1 but not-2 in human aortic smooth muscle cells by inflammatory stimuli. J Steroid Biochem Mol Biol 77:117–122PubMedCrossRefGoogle Scholar
  13. 13.
    Whorwood CB, Franklyn JA, Sheppard MC, Stewart PM (1992) Tissue localization of 11 beta-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor. J Steroid Biochem Mol Biol 41:21–28PubMedCrossRefGoogle Scholar
  14. 14.
    Vogeser M, Zachoval R, Felbinger TW, Jacob K (2002) Increased ratio of serum cortisol to cortisone in acute-phase response. Horm Res 58:172–175PubMedCrossRefGoogle Scholar
  15. 15.
    Vogeser M, Felbinger TW, Roll W, Jacob K (1999) Cortisol metabolism in the postoperative period after cardiac surgery. Exp Clin Endocrinol Diabetes 107:539–546PubMedCrossRefGoogle Scholar
  16. 16.
    Baker RW, Walker BR, Shaw RJ, et al (2000) Increased cortisol: cortisone ratio in acute pulmonary tuberculosis. Am J Respir Crit Care Med 162:1641–1647PubMedGoogle Scholar
  17. 17.
    Hennebold JD, Ryu SY, Mu HH, Galbraith A, Daynes RA (1996) 11 beta-hydroxysteroid dehydrogenase modulation of glucocorticoid activities in lymphoid organs. Am J Physiol 270: R1296–1306PubMedGoogle Scholar
  18. 18.
    Venkatesh B, Cohen J, Hickman I, et al (2007) Evidence of altered cortisol metabolism in critically ill patients: a prospective study. Intensive Care Med 33:1746–1753PubMedCrossRefGoogle Scholar
  19. 19.
    Hewitt KN, Walker EA, Stewart PM (2005) Minireview: hexose-6-phosphate dehydrogenase and redox control of 11ta-hydroxysteroid dehydrogenase type 1 activity. Endocrinology 146:2539–2543Google Scholar
  20. 20.
    Victor VM, Rocha M, De la Fuente M (2004) Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol 4:327–347PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media Inc. 2008

Authors and Affiliations

  • B. Venkatesh
    • 1
  • J. Cohen
    • 2
  1. 1.Department of Intensive Care Princess Alexandra & Wesley HospitalsUniversity of QueenslandQueenslandAustralia
  2. 2.Department of Intensive Care Royal Brisbane & Ipswich HospitalsUniversity of QueenslandQueenslandAustralia

Personalised recommendations